Stay updated on Ensifentrine in COPD Patients: Safety & Efficacy Clinical Trial

Sign up to get notified when there's something new on the Ensifentrine in COPD Patients: Safety & Efficacy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ensifentrine in COPD Patients: Safety & Efficacy Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Page revision updated from v3.5.4 to v3.5.5, signaling a new version of the ClinicalTrials.gov page. This is a deployment-level update and does not modify the study data or presented details.
    Difference
    0.0%
    Check dated 2026-06-05T09:56:15.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page now displays a new revision label (v3.5.4) replacing the previous v3.5.3, indicating an updated software release.
    Difference
    0.0%
    Check dated 2026-05-15T04:59:36.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The sponsor designation in the study details was updated from Verona Pharma plc to Verona Pharma, Inc., a subsidiary of Merck & Co., Inc., Rahway, NJ, signaling a change in the corporate structure and sponsor organization used for the trial.
    Difference
    0.1%
    Check dated 2026-05-08T00:26:51.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.3, replacing v3.5.2, indicating an updated page version rather than a substantive content change.
    Difference
    0.0%
    Check dated 2026-04-30T18:10:45.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Summary
    No changes were detected in the provided additions/deletions inputs.
    Difference
    0.0%
    Check dated 2026-04-23T15:26:22.000Z thumbnail image
  8. Check
    51 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-16T11:52:25.000Z thumbnail image

Stay in the know with updates to Ensifentrine in COPD Patients: Safety & Efficacy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ensifentrine in COPD Patients: Safety & Efficacy Clinical Trial page.